Abdullah Sezer

Abdullah Sezer

Auto-generated profile, based on publicly available information

Abdullah Sezer

Department of Medical Genetics, Ankara Etlik City Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2024 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
MKMustafa Kılıç
Mustafa Kılıç
SISuzan İcIl
Suzan İcIl
ASAbdullah Sezer
Abdullah Sezer
ÖKÖznur Kaya-Güneş
Öznur Kaya-Güneş
SCSelim S. Comoğlu
Selim S. Comoğlu
Objectives: Sialidosis type 1 is a rare autosomal recessive lysosomal storage disorder caused by pathogenic variants in the NEU1 gene, which encodes the sialic acid-degrading enzyme α-neuraminidase. Sialidosis type 1 is a milder form with a late-onset phenotype, characterized by progressive myoclonic epilepsy and ataxia with cherry-red spots. Sialidosis type 2 is an early-onset and more severe form presenting with dysmorphic features, hepatosplenomegaly and cognitive delay. Clinical diagnosis is usually supported by increased urinary bound sialic acid excretion and confirmed by genetic analysis or demonstration of α-neuraminidase enzyme deficiency in cultured fibroblasts. The aim of this study was to present a case of type 1 sialidosis, review the literature, and investigate genotype–phenotype correlations, symptom frequencies, and race-specific mutations in patients diagnosed with type 1 sialidosis. Case presentation: We report herein a family of four Turkish siblings affected with sialidosis type 1 associated with a homozygous variant, c.403G>A p. (Asp135Asn), in the NEU1 gene. A systematic literature review on sialidosis type 1 was carried out, by the PubMed database was searched using keywords included sialidosis and/or NEU1 gene. We selected case reports or series that included genetically confirmed type 1 sialidosis from 1996 to 2023. So far, nearly genetically confirmed 80 patients from unrelated 65 families, more than 40 NEU1 disease causing mutations, have been identified in patients with sialidosis type 1. Among the reported mutations, missense variants are the most common, and few nonsense, frameshift, exonic duplications or small deletions have been reported. c.239C>T p. (Pro80Leu) variant in Chinese and Japanese patients, c.649G>A p. (Val217Met) variant in Japanese patients, c.880C>T p. (Arg294Cys) variant in Indian patients, c.629C>T p. (Pro210Leu) variant in Ecuadorian patients, c.982G>A p. (Gly328Ser) variant in Italian patients, and c.403G>A p (Asp135Asn) and c.625del p. (Glu209Serfs*94) variants in Turkish patients were found higher. Conclusions: Race-specific variants were found with higher percentages in certain populations.

4 July 2025 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
ASAbdullah Sezer
Abdullah Sezer
SOSukru S. Oner
Sukru S. Oner
HSHanife Saat
Hanife Saat
MTMerve G. Turan
Merve G. Turan
TGTulin Gungor
Tulin Gungor
OKOktay I. Kaplan
Oktay I. Kaplan
Cranioectodermal dysplasia (CED) is a ciliopathy characterized by skeletal and ectodermal abnormalities, renal failure, and liver fibrosis. Pathogenic variants in genes that encode the intraflagellar transport (IFT) complex components, particularly IFT-A, are responsible for approximately two-thirds of the CED cases. However, the cause of the remaining cases remains unknown. Ciliogenesis-associated kinase 1 (CILK1) is a highly conserved ciliary serine/threonine kinase with an N-terminal catalytic domain responsible for kinase activity and a C-terminal non-catalytic domain that interacts with the IFT-B complex. Biallelic variants in the catalytic domain are associated with lethal skeletal dysplasia, endocrine cerebroosteodysplasia, and short-rib polydactyly syndrome. No human disease has been linked to biallelic variants in the non-catalytic domain. We present a homozygous frameshift variant in the CILK1 gene that affects the distal part of the non-catalytic domain, causing CED in five patients from two pedigrees. All the patients survived into childhood and had disproportionately short stature, skeletal abnormalities, ectodermal dysplasia, renal issues, and liver complications. Functional data from patient-derived cells and the C. elegans model indicate that the variant reduces cilia number, increases cilia length, and disrupts the localization of IFT components. In contrast, the ciliary localization of CILK1 bearing the variant itself remains unaffected. Notably, we rescued the majority of these abnormalities by reintroducing CILK1 into patient-derived cells. Finally, our study describes CILK1 as a novel causal gene and the first non-IFT protein-encoding gene in the etiology of CED, thus expanding the known genotypic, mechanistic, and phenotypic spectrum of CED.

16 August 2024 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
ASAbdullah Sezer
Abdullah Sezer
ZÖZeynep Özdemir
Zeynep Özdemir
EÖErdem Özkan
Erdem Özkan
SÇSemra Çetinkaya
Semra Çetinkaya

23 May 2023 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
TDTarik Duzenli
Tarik Duzenli
ASAbdullah Sezer
Abdullah Sezer
GKGulsum Kayhan
Gulsum Kayhan
AAAyse Tana Arslan
Ayse Tana Arslan
FPFerda E. Percin
Ferda E. Percin

6 March 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
ASAbdullah Sezer
Abdullah Sezer
FPFerda Emriye Perçin
Ferda Emriye Perçin
HKHasan Huseyin Kazan
Hasan Huseyin Kazan
GKGulsum Kayhan
Gulsum Kayhan
MAMujde Akturk
Mujde Akturk

6 June 2024 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
ETElifcan Taşdelen
Elifcan Taşdelen
ASAbdullah Sezer
Abdullah Sezer
IAIsa An
Isa An